Signal #149865 · SEC 8-K

$KROS SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $KROS filing catalyst

Why did $KROS trigger an AI stock catalyst alert?

$KROS triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +4.5/10). Headline: Keros Therapeutics Reports Q3 2026 Net Income of $14.2M Driven by Takeda License. Key points: - Net income reached $14.2M vs. net loss of $7.3M in Q3 2025, driven by Takeda licensing revenue recognition. - Diluted EPS came in at $0.70; cash and cash equivalents totaled $259.5M as of September 30, 2026. - Management expects cash runway to extend into the second half of 2028.

How did $KROS stock react after the SEC filing?

After the SEC 8-K for $KROS, observed market reaction: T0 price $9.45. Past moves do not guarantee future results.

Where can I get real-time $KROS SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $KROS via Telegram and the VIP Web Terminal from €10/month.

$KROS

$KROS – Keros Therapeutics Reports Q3 2026 Net Income of $14.2M Driven by Takeda License

Keros Therapeutics, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $KROS

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+4.5 / 10)

Net income reached $14.2M vs. net loss of $7.3M in Q3 2025, driven by Takeda licensing revenue recognition.
Diluted EPS came in at $0.70; cash and cash equivalents totaled $259.5M as of September 30, 2026.
Management expects cash runway to extend into the second half of 2028.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →